ArticleMolecules (Basel, Switzerland)2023

In Silico Investigation of the Molecular Mechanism of PARP1 Inhibition for the Treatment of BRCA-Deficient Cancers.

Fengqin Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.